An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
End Stage Renal Disease
Interventions
DEVICE

Theranova Dialyzer

The Theranova dialyzer will be used for each of the hemodialysis treatments beginning week 5 and ending at the end of dialysis week 28. This will allow us to compare patient reported symptoms in weeks 1-4 on their usual dialyzer with with their symptoms on the Theranova dialyzer.

Trial Locations (2)

N6A 5W9

RECRUITING

Victoria Hospital, London Health Sciences Centre, London

N6K 1M6

RECRUITING

Westmount Kidney Care Centre, London

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT06032208 - An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL | Biotech Hunter | Biotech Hunter